sales@starshinechemical.com
CAS RN: 125-84-8
DL-Aminoglutethimide
- Product code: ICTA1947
- Purity/Analytical Methods: >98.0%(T)(HPLC)
Basic Information
| Appearance and Shape (20°C) | Solid |
|---|---|
| CAS RN | 125-84-8 |
| MDL number | MFCD00010122 |
| Molecular weight | 232.28 |
| Molecular Formula | C13H16N2O2 |
| Product code | ICTA1947 |
| PubChem Substance ID | 87558926 |
| Purity/Analytical Methods | >98.0%(T)(HPLC) |
| Reaxys-RN | 210656 |
Technical Specifications
Technical Specifications
| Appearance | White to Light yellow powder to crystal |
|---|
Safety and Regulatory
GHS
| Pictograms |
|
|---|---|
| Hazard statement | H315 : Causes skin irritation H319 : Causes serious eye irritation. |
| Precautionary Statements | P264 : Wash skin thoroughly after handling P280 : Wear protective gloves/ eye protection/ face protection P337 + P313 : If eye irritation persists: Get medical advice/ attention P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P302 + P352 : IF ON SKIN: Wash with plenty of soap and water P332 + P313 : If skin irritation occurs: Get medical advice/ attention P362 : Take off contaminated clothing and wash before reuse. |
| Signal word | Warning |
Related legislation
| RTECS# | MA4026950 |
|---|
Product Category
Chemical structure
Life Science Biochemicals and Reagents Enzymes, Enzyme Inhibitors, Enzyme Substrates Enzyme Inhibitors [Biochemicals and Reagents] Enzyme Inhibitors [A to C] Aromatase Inhibitors Enzyme Inhibitors by Enzyme Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Ingredients (for Research and Experimental Use) Hormonal Antitumor Agents Cell Biology Cancer Research Antitumor Agents Aromatase Inhibitors [Cancer Research] Cytochrome P450 (CYP) Inhibitors Tumor Growth Regulation Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Ingredients (for Research and Experimental Use) Hormonal Antitumor Agents